Refuse-to-File Turns 25: New Guidance Changes In Style, But Not Substance

US FDA’s revised draft guidance spelling out its policy on 'refuse-to-file' decisions differs little in substance compared to predecessor issued in 1993. But difference in style is telling sign of the times.

Accept - Refuse_529502731_1200.jpg

The US FDA is replacing its 25 year-old guidance on “Refuse to File” (RTF) decisions for NDA/BLA submissions with a new draft guidance published Dec. 12.

There is very little difference in substance between the new draft and the predecessor guidance issued in 1993. But...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards